APO Research

APO RESEARCH · REPORT

Hypnotics and Sedatives

Selected research

Industry Growth & Trends

Global Hypnotics and Sedatives Industry Growth and Trends Forecast to 2032

Market perspective

The global Hypnotics and Sedatives market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Hypnotics and Sedatives is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Hypnotics and Sedatives is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Hypnotics and Sedatives is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Hypnotics and Sedatives include Abbott, Takeda, Sanofi, Novartis, Mylan, Pfizer, Fresenius Kabi, Baxter and Sands Pharm, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Hypnotics and Sedatives market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Hypnotics and Sedatives market size, estimates, and forecasts are presented in terms of sales volume (k tons) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Hypnotics and Sedatives market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Hypnotics and Sedatives.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Hypnotics and Sedatives market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Hypnotics and Sedatives Market by Company

Abbott

Takeda

Sanofi

Novartis

Mylan

Pfizer

Fresenius Kabi

Baxter

Sands Pharm

Hospira

Cobalt Laboratories

Hypnotics and Sedatives Segment by Type

Capsule

Solution

Suppository

Injectable

Hypnotics and Sedatives Segment by Application

Hospital

Clinic

Hypnotics and Sedatives Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Hypnotics and Sedatives market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Hypnotics and Sedatives and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Hypnotics and Sedatives.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Hypnotics and Sedatives manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Hypnotics and Sedatives in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Capsule Table 2. Major Company of Solution Table 3. Major Company of Suppository Table 4. Major Company of Injectable Table 5. Global Hypnotics and Sedatives Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 6. Global Hypnotics and Sedatives Sales by Type (2021-2026) & (k tons) Table 7. Global Hypnotics and Sedatives Sales Market Share in Volume by Type (2021-2026) Table 8. Global Hypnotics and Sedatives Sales by Type (2021-2026) & (US$ Million) Table 9. Global Hypnotics and Sedatives Sales Market Share in Value by Type (2021-2026) Table 10. Global Hypnotics and Sedatives Price by Type (2021-2026) & (US$/ton) Table 11. Global Hypnotics and Sedatives Sales by Type (2027-2032) & (k tons) Table 12. Global Hypnotics and Sedatives Sales Market Share in Volume by Type (2027-2032) Table 13. Global Hypnotics and Sedatives Sales by Type (2027-2032) & (US$ Million) Table 14. Global Hypnotics and Sedatives Sales Market Share in Value by Type (2027-2032) Table 15. Global Hypnotics and Sedatives Price by Type (2027-2032) & (US$/ton) Table 16. North America Hypnotics and Sedatives Sales by Type (2021-2026) & (k tons) Table 17. North America Hypnotics and Sedatives Sales by Type (2021-2026) & (US$ Million) Table 18. Europe Hypnotics and Sedatives Sales by Type (2021-2026) & (k tons) Table 19. Europe Hypnotics and Sedatives Sales by Type (2021-2026) & (US$ Million) Table 20. Asia-Pacific Hypnotics and Sedatives Sales by Type (2021-2026) & (k tons) Table 21. Asia-Pacific Hypnotics and Sedatives Sales by Type (2021-2026) & (US$ Million) Table 22. Latin America Hypnotics and Sedatives Sales by Type (2021-2026) & (k tons) Table 23. Latin America Hypnotics and Sedatives Sales by Type (2021-2026) & (US$ Million) Table 24. Middle East and Africa Hypnotics and Sedatives Sales by Type (2021-2026) & (k tons) Table 25. Middle East and Africa Hypnotics and Sedatives Sales by Type (2021-2026) & (US$ Million) Table 26. Hypnotics and Sedatives Industry Trends Table 27. Hypnotics and Sedatives Industry Drivers Table 28. Hypnotics and Sedatives Industry Opportunities and Challenges Table 29. Hypnotics and Sedatives Industry Restraints Table 30. Global Hypnotics and Sedatives Sales Revenue by Company (US$ Million) & (2021-2026) Table 31. Global Hypnotics and Sedatives Revenue Market Share by Company (2021-2026) Table 32. Global Hypnotics and Sedatives Sales by Company (2021-2026) & (k tons) Table 33. Global Hypnotics and Sedatives Sales Share by Company (2021-2026) Table 34. Global Hypnotics and Sedatives Market Price by Company (2021-2026) & (US$/ton) Table 35. Global Hypnotics and Sedatives Industry Company Ranking, 2024 VS 2025 VS 2026 Table 36. Global Hypnotics and Sedatives Major Company Production Sites and Headquarters Table 37. Global Hypnotics and Sedatives Company, Product Type & Application Table 38. Global Hypnotics and Sedatives Company Establishment Date Table 39. Global Company Market Concentration Ratio (CR5 and HHI) Table 40. Global Hypnotics and Sedatives by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 41. Global Hypnotics and Sedatives Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 42. Global Hypnotics and Sedatives Sales by Region (2021-2026) & (k tons) Table 43. Global Hypnotics and Sedatives Sales Market Share in Volume by Region (2021-2026) Table 44. Global Hypnotics and Sedatives Sales by Region (2021-2026) & (US$ Million) Table 45. Global Hypnotics and Sedatives Sales Market Share in Value by Region (2021-2026) Table 46. Global Hypnotics and Sedatives Sales (k tons), Value (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 47. Global Hypnotics and Sedatives Sales by Region (2027-2032) & (k tons) Table 48. Global Hypnotics and Sedatives Sales Market Share in Volume by Region (2027-2032) Table 49. Global Hypnotics and Sedatives Sales by Region (2027-2032) & (US$ Million) Table 50. Global Hypnotics and Sedatives Sales Market Share in Value by Region (2027-2032) Table 51. Global Hypnotics and Sedatives Sales (k tons), Value (US$ Million), Price (US$/ton) and Gross Margin (2027-2032) Table 52. Global Hypnotics and Sedatives Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 53. Global Hypnotics and Sedatives Sales by Application (2021-2026) & (k tons) Table 54. Global Hypnotics and Sedatives Sales Market Share in Volume by Application (2021-2026) Table 55. Global Hypnotics and Sedatives Sales by Application (2021-2026) & (US$ Million) Table 56. Global Hypnotics and Sedatives Sales Market Share in Value by Application (2021-2026) Table 57. Global Hypnotics and Sedatives Price by Application (2021-2026) & (US$/ton) Table 58. Global Hypnotics and Sedatives Sales by Application (2027-2032) & (k tons) Table 59. Global Hypnotics and Sedatives Sales Market Share in Volume by Application (2027-2032) Table 60. Global Hypnotics and Sedatives Sales by Application (2027-2032) & (US$ Million) Table 61. Global Hypnotics and Sedatives Sales Market Share in Value by Application (2027-2032) Table 62. Global Hypnotics and Sedatives Price by Application (2027-2032) & (US$/ton) Table 63. North America Hypnotics and Sedatives Sales by Application (2021-2026) & (k tons) Table 64. North America Hypnotics and Sedatives Sales by Application (2021-2026) & (US$ Million) Table 65. Europe Hypnotics and Sedatives Sales by Application (2021-2026) & (k tons) Table 66. Europe Hypnotics and Sedatives Sales by Application (2021-2026) & (US$ Million) Table 67. Asia-Pacific Hypnotics and Sedatives Sales by Application (2021-2026) & (k tons) Table 68. Asia-Pacific Hypnotics and Sedatives Sales by Application (2021-2026) & (US$ Million) Table 69. Latin America Hypnotics and Sedatives Sales by Application (2021-2026) & (k tons) Table 70. Latin America Hypnotics and Sedatives Sales by Application (2021-2026) & (US$ Million) Table 71. Middle East and Africa Hypnotics and Sedatives Sales by Application (2021-2026) & (k tons) Table 72. Middle East and Africa Hypnotics and Sedatives Sales by Application (2021-2026) & (US$ Million) Table 73. Abbott Company Information Table 74. Abbott Business Overview Table 75. Abbott Hypnotics and Sedatives Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 76. Abbott Hypnotics and Sedatives Product Portfolio Table 77. Abbott Recent Development Table 78. Takeda Company Information Table 79. Takeda Business Overview Table 80. Takeda Hypnotics and Sedatives Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 81. Takeda Hypnotics and Sedatives Product Portfolio Table 82. Takeda Recent Development Table 83. Sanofi Company Information Table 84. Sanofi Business Overview Table 85. Sanofi Hypnotics and Sedatives Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 86. Sanofi Hypnotics and Sedatives Product Portfolio Table 87. Sanofi Recent Development Table 88. Novartis Company Information Table 89. Novartis Business Overview Table 90. Novartis Hypnotics and Sedatives Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 91. Novartis Hypnotics and Sedatives Product Portfolio Table 92. Novartis Recent Development Table 93. Mylan Company Information Table 94. Mylan Business Overview Table 95. Mylan Hypnotics and Sedatives Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 96. Mylan Hypnotics and Sedatives Product Portfolio Table 97. Mylan Recent Development Table 98. Pfizer Company Information Table 99. Pfizer Business Overview Table 100. Pfizer Hypnotics and Sedatives Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 101. Pfizer Hypnotics and Sedatives Product Portfolio Table 102. Pfizer Recent Development Table 103. Fresenius Kabi Company Information Table 104. Fresenius Kabi Business Overview Table 105. Fresenius Kabi Hypnotics and Sedatives Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 106. Fresenius Kabi Hypnotics and Sedatives Product Portfolio Table 107. Fresenius Kabi Recent Development Table 108. Baxter Company Information Table 109. Baxter Business Overview Table 110. Baxter Hypnotics and Sedatives Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 111. Baxter Hypnotics and Sedatives Product Portfolio Table 112. Baxter Recent Development Table 113. Sands Pharm Company Information Table 114. Sands Pharm Business Overview Table 115. Sands Pharm Hypnotics and Sedatives Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 116. Sands Pharm Hypnotics and Sedatives Product Portfolio Table 117. Sands Pharm Recent Development Table 118. Hospira Company Information Table 119. Hospira Business Overview Table 120. Hospira Hypnotics and Sedatives Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 121. Hospira Hypnotics and Sedatives Product Portfolio Table 122. Hospira Recent Development Table 123. Cobalt Laboratories Company Information Table 124. Cobalt Laboratories Business Overview Table 125. Cobalt Laboratories Hypnotics and Sedatives Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 126. Cobalt Laboratories Hypnotics and Sedatives Product Portfolio Table 127. Cobalt Laboratories Recent Development Table 128. North America Hypnotics and Sedatives Market Size Growth Rate (CAGR) by Country (k tons): 2021 VS 2025 VS 2032 Table 129. North America Hypnotics and Sedatives Sales by Country (2021-2026) & (k tons) Table 130. North America Hypnotics and Sedatives Sales Market Share by Country (2021-2026) Table 131. North America Hypnotics and Sedatives Sales Forecast by Country (2027-2032) & (k tons) Table 132. North America Hypnotics and Sedatives Sales Market Share Forecast by Country (2027-2032) Table 133. North America Hypnotics and Sedatives Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 134. North America Hypnotics and Sedatives Market Size by Country (2021-2026) & (US$ Million) Table 135. North America Hypnotics and Sedatives Market Share by Country (2021-2026) Table 136. North America Hypnotics and Sedatives Market Size Forecast by Country (2027-2032) & (US$ Million) Table 137. North America Hypnotics and Sedatives Market Share Forecast by Country (2027-2032) Table 138. Europe Hypnotics and Sedatives Market Size Growth Rate (CAGR) by Country (k tons): 2021 VS 2025 VS 2032 Table 139. Europe Hypnotics and Sedatives Sales by Country (2021-2026) & (k tons) Table 140. Europe Hypnotics and Sedatives Sales Market Share by Country (2021-2026) Table 141. Europe Hypnotics and Sedatives Sales Forecast by Country (2027-2032) & (k tons) Table 142. Europe Hypnotics and Sedatives Sales Market Share Forecast by Country (2027-2032) Table 143. Europe Hypnotics and Sedatives Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 144. Europe Hypnotics and Sedatives Market Size by Country (2021-2026) & (US$ Million) Table 145. Europe Hypnotics and Sedatives Market Share by Country (2021-2026) Table 146. Europe Hypnotics and Sedatives Market Size Forecast by Country (2027-2032) & (US$ Million) Table 147. Europe Hypnotics and Sedatives Market Share Forecast by Country (2027-2032) Table 148. Asia-Pacific Hypnotics and Sedatives Market Size Growth Rate (CAGR) by Country (k tons): 2021 VS 2025 VS 2032 Table 149. Asia-Pacific Hypnotics and Sedatives Sales by Country (2021-2026) & (k tons) Table 150. Asia-Pacific Hypnotics and Sedatives Sales Market Share by Country (2021-2026) Table 151. Asia-Pacific Hypnotics and Sedatives Sales Forecast by Country (2027-2032) & (k tons) Table 152. Asia-Pacific Hypnotics and Sedatives Sales Market Share Forecast by Country (2027-2032) Table 153. Asia-Pacific Hypnotics and Sedatives Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 154. Asia-Pacific Hypnotics and Sedatives Market Size by Country (2021-2026) & (US$ Million) Table 155. Asia-Pacific Hypnotics and Sedatives Market Share by Country (2021-2026) Table 156. Asia-Pacific Hypnotics and Sedatives Market Size Forecast by Country (2027-2032) & (US$ Million) Table 157. Asia-Pacific Hypnotics and Sedatives Market Share Forecast by Country (2027-2032) Table 158. Latin America Hypnotics and Sedatives Market Size Growth Rate (CAGR) by Country (k tons): 2021 VS 2025 VS 2032 Table 159. Latin America Hypnotics and Sedatives Sales by Country (2021-2026) & (k tons) Table 160. Latin America Hypnotics and Sedatives Sales Market Share by Country (2021-2026) Table 161. Latin America Hypnotics and Sedatives Sales Forecast by Country (2027-2032) & (k tons) Table 162. Latin America Hypnotics and Sedatives Sales Market Share Forecast by Country (2027-2032) Table 163. Latin America Hypnotics and Sedatives Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 164. Latin America Hypnotics and Sedatives Market Size by Country (2021-2026) & (US$ Million) Table 165. Latin America Hypnotics and Sedatives Market Share by Country (2021-2026) Table 166. Latin America Hypnotics and Sedatives Market Size Forecast by Country (2027-2032) & (US$ Million) Table 167. Latin America Hypnotics and Sedatives Market Share Forecast by Country (2027-2032) Table 168. Middle East and Africa Hypnotics and Sedatives Market Size Growth Rate (CAGR) by Country (k tons): 2021 VS 2025 VS 2032 Table 169. Middle East and Africa Hypnotics and Sedatives Sales by Country (2021-2026) & (k tons) Table 170. Middle East and Africa Hypnotics and Sedatives Sales Market Share by Country (2021-2026) Table 171. Middle East and Africa Hypnotics and Sedatives Sales Forecast by Country (2027-2032) & (k tons) Table 172. Middle East and Africa Hypnotics and Sedatives Sales Market Share Forecast by Country (2027-2032) Table 173. Middle East and Africa Hypnotics and Sedatives Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 174. Middle East and Africa Hypnotics and Sedatives Market Size by Country (2021-2026) & (US$ Million) Table 175. Middle East and Africa Hypnotics and Sedatives Market Share by Country (2021-2026) Table 176. Middle East and Africa Hypnotics and Sedatives Market Size Forecast by Country (2027-2032) & (US$ Million) Table 177. Middle East and Africa Hypnotics and Sedatives Market Share Forecast by Country (2027-2032) Table 178. Key Raw Materials Table 179. Raw Materials Key Suppliers Table 180. Hypnotics and Sedatives Distributors List Table 181. Hypnotics and Sedatives Customers List Table 182. Research Programs/Design for This Report Table 183. Authors List of This Report Table 184. Secondary Sources Table 185. Primary Sources List of Figures Figure 1. Hypnotics and Sedatives Image Figure 2. Global Hypnotics and Sedatives Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Hypnotics and Sedatives Market Size (2021-2032) & (US$ Million) Figure 4. Global Hypnotics and Sedatives Sales (2021-2032) & (k tons) Figure 5. Capsule Image Figure 6. Global Capsule Sales YoY Growth (2021-2032) & (k tons) Figure 7. Solution Image Figure 8. Global Solution Sales YoY Growth (2021-2032) & (k tons) Figure 9. Suppository Image Figure 10. Global Suppository Sales YoY Growth (2021-2032) & (k tons) Figure 11. Injectable Image Figure 12. Global Injectable Sales YoY Growth (2021-2032) & (k tons) Figure 13. Global Hypnotics and Sedatives Market Size Overview by Type (2021-2032) & (US$ Million) Figure 14. Global Hypnotics and Sedatives Market Share by Type 2025 VS 2032 Figure 15. North America Hypnotics and Sedatives Sales Market Share in Volume by Type in 2025 Figure 16. North America Hypnotics and Sedatives Sales Market Share in Value by Type in 2025 Figure 17. Europe Hypnotics and Sedatives Sales Market Share in Volume by Type in 2025 Figure 18. Europe Hypnotics and Sedatives Sales Market Share in Value by Type in 2025 Figure 19. Asia-Pacific Hypnotics and Sedatives Sales Market Share in Volume by Type in 2025 Figure 20. Asia-Pacific Hypnotics and Sedatives Sales Market Share in Value by Type in 2025 Figure 21. Latin America Hypnotics and Sedatives Sales Market Share in Volume by Type in 2025 Figure 22. Latin America Hypnotics and Sedatives Sales Market Share in Value by Type in 2025 Figure 23. Middle East and Africa Hypnotics and Sedatives Sales Market Share in Volume by Type in 2025 Figure 24. Middle East and Africa Hypnotics and Sedatives Sales Market Share in Value by Type in 2025 Figure 25. Global Top 5 and 10 Hypnotics and Sedatives Players Market Share by Revenue in 2025 Figure 26. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Hospital Image Figure 28. Global Hospital Sales YoY Growth (2021-2032) & (k tons) Figure 29. Clinic Image Figure 30. Global Clinic Sales YoY Growth (2021-2032) & (k tons) Figure 31. Global Hypnotics and Sedatives Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Hypnotics and Sedatives Market Share by Application 2025 VS 2032 Figure 33. North America Hypnotics and Sedatives Sales Market Share in Volume by Application in 2025 Figure 34. North America Hypnotics and Sedatives Sales Market Share in Value by Application in 2025 Figure 35. Europe Hypnotics and Sedatives Sales Market Share in Volume by Application in 2025 Figure 36. Europe Hypnotics and Sedatives Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Hypnotics and Sedatives Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Hypnotics and Sedatives Sales Market Share in Value by Application in 2025 Figure 39. Latin America Hypnotics and Sedatives Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Hypnotics and Sedatives Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Hypnotics and Sedatives Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Hypnotics and Sedatives Sales Market Share in Value by Application in 2025 Figure 43. North America Hypnotics and Sedatives Sales by Country: 2021 VS 2025 VS 2032 (k tons) Figure 44. North America Hypnotics and Sedatives Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Hypnotics and Sedatives Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Hypnotics and Sedatives Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Hypnotics and Sedatives Sales by Country: 2021 VS 2025 VS 2032 (k tons) Figure 48. Europe Hypnotics and Sedatives Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Hypnotics and Sedatives Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Hypnotics and Sedatives Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Hypnotics and Sedatives Sales by Country: 2021 VS 2025 VS 2032 (k tons) Figure 52. Asia-Pacific Hypnotics and Sedatives Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Hypnotics and Sedatives Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Hypnotics and Sedatives Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Hypnotics and Sedatives Sales by Country: 2021 VS 2025 VS 2032 (k tons) Figure 56. Latin America Hypnotics and Sedatives Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Hypnotics and Sedatives Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Hypnotics and Sedatives Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Hypnotics and Sedatives Sales by Country: 2021 VS 2025 VS 2032 (k tons) Figure 60. Middle East and Africa Hypnotics and Sedatives Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Hypnotics and Sedatives Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Hypnotics and Sedatives Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Hypnotics and Sedatives Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Hypnotics and Sedatives Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Capsule
  • Solution
  • Suppository
  • Injectable
Applications
  • Hospital
  • Clinic
Companies covered
  • Abbott
  • Takeda
  • Sanofi
  • Novartis
  • Mylan
  • Pfizer
  • Fresenius Kabi
  • Baxter
  • Sands Pharm
  • Hospira
  • Cobalt Laboratories

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Hypnotics and Sedatives Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Hypnotics and Sedatives Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Hypnotics and Sedatives Market by Type
  6. 1.3.1 Capsule
  7. 1.3.2 Solution
  8. 1.3.3 Suppository
  9. 1.3.4 Injectable
  10. 1.4 Global Hypnotics and Sedatives Market Size by Type
  11. 1.4.1 Global Hypnotics and Sedatives Market Size Overview by Type (2021-2032)
  12. 1.4.2 Global Hypnotics and Sedatives Historic Market Size Review by Type (2021-2026)
  13. 1.4.3 Global Hypnotics and Sedatives Forecasted Market Size by Type (2027-2032)
  14. 1.5 Key Regions Market Size by Type
  15. 1.5.1 North America Hypnotics and Sedatives Sales Breakdown by Type (2021-2026)
  16. 1.5.2 Europe Hypnotics and Sedatives Sales Breakdown by Type (2021-2026)
  17. 1.5.3 Asia-Pacific Hypnotics and Sedatives Sales Breakdown by Type (2021-2026)
  18. 1.5.4 South America Hypnotics and Sedatives Sales Breakdown by Type (2021-2026)
  19. 1.5.5 Middle East and Africa Hypnotics and Sedatives Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Hypnotics and Sedatives Industry Trends
  2. 2.2 Hypnotics and Sedatives Industry Drivers
  3. 2.3 Hypnotics and Sedatives Industry Opportunities and Challenges
  4. 2.4 Hypnotics and Sedatives Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Hypnotics and Sedatives Revenue (2021-2026)
  2. 3.2 Global Top Players by Hypnotics and Sedatives Sales (2021-2026)
  3. 3.3 Global Top Players by Hypnotics and Sedatives Price (2021-2026)
  4. 3.4 Global Hypnotics and Sedatives Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Hypnotics and Sedatives Major Company Production Sites & Headquarters
  6. 3.6 Global Hypnotics and Sedatives Company, Product Type & Application
  7. 3.7 Global Hypnotics and Sedatives Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Hypnotics and Sedatives Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Hypnotics and Sedatives Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Hypnotics and Sedatives Tier 1, Tier 2, and Tier 3
4 Hypnotics and Sedatives Regional Status and Outlook
  1. 4.1 Global Hypnotics and Sedatives Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Hypnotics and Sedatives Historic Market Size by Region
  3. 4.2.1 Global Hypnotics and Sedatives Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Hypnotics and Sedatives Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Hypnotics and Sedatives Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Hypnotics and Sedatives Forecasted Market Size by Region
  7. 4.3.1 Global Hypnotics and Sedatives Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Hypnotics and Sedatives Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Hypnotics and Sedatives Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Hypnotics and Sedatives by Application
  1. 5.1 Hypnotics and Sedatives Market by Application
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.2 Global Hypnotics and Sedatives Market Size by Application
  5. 5.2.1 Global Hypnotics and Sedatives Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Hypnotics and Sedatives Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Hypnotics and Sedatives Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Hypnotics and Sedatives Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Hypnotics and Sedatives Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Hypnotics and Sedatives Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Hypnotics and Sedatives Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Hypnotics and Sedatives Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Abbott
  2. 6.1.1 Abbott Company Information
  3. 6.1.2 Abbott Business Overview
  4. 6.1.3 Abbott Hypnotics and Sedatives Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Abbott Hypnotics and Sedatives Product Portfolio
  6. 6.1.5 Abbott Recent Developments
  7. 6.2 Takeda
  8. 6.2.1 Takeda Company Information
  9. 6.2.2 Takeda Business Overview
  10. 6.2.3 Takeda Hypnotics and Sedatives Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Takeda Hypnotics and Sedatives Product Portfolio
  12. 6.2.5 Takeda Recent Developments
  13. 6.3 Sanofi
  14. 6.3.1 Sanofi Company Information
  15. 6.3.2 Sanofi Business Overview
  16. 6.3.3 Sanofi Hypnotics and Sedatives Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Sanofi Hypnotics and Sedatives Product Portfolio
  18. 6.3.5 Sanofi Recent Developments
  19. 6.4 Novartis
  20. 6.4.1 Novartis Company Information
  21. 6.4.2 Novartis Business Overview
  22. 6.4.3 Novartis Hypnotics and Sedatives Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Novartis Hypnotics and Sedatives Product Portfolio
  24. 6.4.5 Novartis Recent Developments
  25. 6.5 Mylan
  26. 6.5.1 Mylan Company Information
  27. 6.5.2 Mylan Business Overview
  28. 6.5.3 Mylan Hypnotics and Sedatives Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Mylan Hypnotics and Sedatives Product Portfolio
  30. 6.5.5 Mylan Recent Developments
  31. 6.6 Pfizer
  32. 6.6.1 Pfizer Company Information
  33. 6.6.2 Pfizer Business Overview
  34. 6.6.3 Pfizer Hypnotics and Sedatives Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Pfizer Hypnotics and Sedatives Product Portfolio
  36. 6.6.5 Pfizer Recent Developments
  37. 6.7 Fresenius Kabi
  38. 6.7.1 Fresenius Kabi Company Information
  39. 6.7.2 Fresenius Kabi Business Overview
  40. 6.7.3 Fresenius Kabi Hypnotics and Sedatives Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Fresenius Kabi Hypnotics and Sedatives Product Portfolio
  42. 6.7.5 Fresenius Kabi Recent Developments
  43. 6.8 Baxter
  44. 6.8.1 Baxter Company Information
  45. 6.8.2 Baxter Business Overview
  46. 6.8.3 Baxter Hypnotics and Sedatives Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Baxter Hypnotics and Sedatives Product Portfolio
  48. 6.8.5 Baxter Recent Developments
  49. 6.9 Sands Pharm
  50. 6.9.1 Sands Pharm Company Information
  51. 6.9.2 Sands Pharm Business Overview
  52. 6.9.3 Sands Pharm Hypnotics and Sedatives Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Sands Pharm Hypnotics and Sedatives Product Portfolio
  54. 6.9.5 Sands Pharm Recent Developments
  55. 6.10 Hospira
  56. 6.10.1 Hospira Company Information
  57. 6.10.2 Hospira Business Overview
  58. 6.10.3 Hospira Hypnotics and Sedatives Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Hospira Hypnotics and Sedatives Product Portfolio
  60. 6.10.5 Hospira Recent Developments
  61. 6.11 Cobalt Laboratories
  62. 6.11.1 Cobalt Laboratories Company Information
  63. 6.11.2 Cobalt Laboratories Business Overview
  64. 6.11.3 Cobalt Laboratories Hypnotics and Sedatives Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Cobalt Laboratories Hypnotics and Sedatives Product Portfolio
  66. 6.11.5 Cobalt Laboratories Recent Developments
7 North America by Country
  1. 7.1 North America Hypnotics and Sedatives Sales by Country
  2. 7.1.1 North America Hypnotics and Sedatives Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Hypnotics and Sedatives Sales by Country (2021-2026)
  4. 7.1.3 North America Hypnotics and Sedatives Sales Forecast by Country (2027-2032)
  5. 7.2 North America Hypnotics and Sedatives Market Size by Country
  6. 7.2.1 North America Hypnotics and Sedatives Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Hypnotics and Sedatives Market Size by Country (2021-2026)
  8. 7.2.3 North America Hypnotics and Sedatives Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Hypnotics and Sedatives Sales by Country
  2. 8.1.1 Europe Hypnotics and Sedatives Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Hypnotics and Sedatives Sales by Country (2021-2026)
  4. 8.1.3 Europe Hypnotics and Sedatives Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Hypnotics and Sedatives Market Size by Country
  6. 8.2.1 Europe Hypnotics and Sedatives Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Hypnotics and Sedatives Market Size by Country (2021-2026)
  8. 8.2.3 Europe Hypnotics and Sedatives Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Hypnotics and Sedatives Sales by Country
  2. 9.1.1 Asia-Pacific Hypnotics and Sedatives Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Hypnotics and Sedatives Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Hypnotics and Sedatives Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Hypnotics and Sedatives Market Size by Country
  6. 9.2.1 Asia-Pacific Hypnotics and Sedatives Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Hypnotics and Sedatives Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Hypnotics and Sedatives Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Hypnotics and Sedatives Sales by Country
  2. 10.1.1 South America Hypnotics and Sedatives Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Hypnotics and Sedatives Sales by Country (2021-2026)
  4. 10.1.3 South America Hypnotics and Sedatives Sales Forecast by Country (2027-2032)
  5. 10.2 South America Hypnotics and Sedatives Market Size by Country
  6. 10.2.1 South America Hypnotics and Sedatives Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Hypnotics and Sedatives Market Size by Country (2021-2026)
  8. 10.2.3 South America Hypnotics and Sedatives Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Hypnotics and Sedatives Sales by Country
  2. 11.1.1 Middle East and Africa Hypnotics and Sedatives Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Hypnotics and Sedatives Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Hypnotics and Sedatives Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Hypnotics and Sedatives Market Size by Country
  6. 11.2.1 Middle East and Africa Hypnotics and Sedatives Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Hypnotics and Sedatives Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Hypnotics and Sedatives Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Hypnotics and Sedatives Value Chain Analysis
  2. 12.1.1 Hypnotics and Sedatives Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Hypnotics and Sedatives Production Mode & Process
  7. 12.2 Hypnotics and Sedatives Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Hypnotics and Sedatives Distributors
  10. 12.2.3 Hypnotics and Sedatives Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research